Pyrimidineamines as angiogenesis modulators
US7105530B2 · kind B2 · utility
46Cited by
4References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 2001 |
| Grant date | Sep 12, 2006 |
| Priority date | — |
| Expiry date | Dec 19, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Pyrimidine derivatives, which are useful as VEGFR2 inhibitors are described herein. The described invention also Includes methods of making such pyrimidine derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.